AIkido Pharma Reports Co. Partner For Securities Purchase Deal, Slinger Bag, Filed IPO To List On Nasdaq
Company's Flagship Product, The Slinger Bag, Top Rated Among 2022 Tennis Products
NEW YORK, May 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today reported
24 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Austin Gold (NYSE: AUST) shares rose 30.3% to $5.70 in pre-market trading after gaining around 9% on Wednesday. Austin Gold had its IPO on Wednesday at $5 per share.
81 Biggest Movers From Yesterday
Gainers
Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
AIkido Pharma Reports Strategic Investment In Social Communications Platform, Discord, No Terms Disclosed; Press Release Says ‘Discord Reportedly Interviewing Investment Bankers About Going Public This Year’
AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today announced that the Company has secured an early equity interest in privately-held Discord, Inc. (https://discord.com/), a social
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
AIkido Pharma Reports Strategic Investment In MasterClass, No Terms Disclosed
AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today announced that the Company has secured an early equity interest in privately-held Yanka Industries, Inc., doing business as
Cedars-Sinai Medical Center And AIkido Pharma Inc. To Codevelop Novel Immuno-Oncology Cancer Treatment
AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today announced that the Company and Cedars-Sinai Medical Center have agreed under their Master Collaboration Agreement to co-fund and
AIkido Pharma Reports Master Collab Deal With Cedars-Sinai Medical Center, No Terms Disclosed
AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today announced that the Company has entered into a Master Collaboration Agreement (MCA) with Cedars-Sinai Medical Center. The purpose of